Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptide Identification Using Tandem Mass Spectrometry01:33

Peptide Identification Using Tandem Mass Spectrometry

8.8K
Tandem mass spectrometry, also known as MS/MS or MS2, is an analytical technique that employs two mass analyzers. Essentially it is a series of mass spectrometers that helps isolate a particular biomolecule and then helps study its chemical properties.
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
8.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis.

Circulation·2018
Same author

Publisher Correction: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.

Nature reviews. Nephrology·2018
Same author

Staging systems use for risk stratification of systemic amyloidosis in the era of high-sensitivity troponin T assay.

Blood·2018
Same author

Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome.

Blood cancer journal·2018
Same author

Autologous Stem Cell Transplant for IgM-Associated Amyloid Light-Chain Amyloidosis.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2018
Same author

Peripheral blood biomarkers of early immune reconstitution in newly diagnosed multiple myeloma.

American journal of hematology·2018

Related Experiment Video

Updated: Mar 26, 2026

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application
04:24

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application

Published on: June 16, 2023

2.5K

Monitoring free light chains in serum using mass spectrometry.

David R Barnidge, Angela Dispenzieri, Giampaolo Merlini

    Clinical Chemistry and Laboratory Medicine
    |February 5, 2016
    PubMed
    Summary
    This summary is machine-generated.

    A new mass spectrometry method accurately detects and quantifies monoclonal free light chains (FLC) in serum. This technique aids in diagnosing plasma cell dyscrasias like multiple myeloma and light chain amyloidosis.

    More Related Videos

    Liquid Chromatography Coupled to Refractive Index or Mass Spectrometric Detection for Metabolite Profiling in Lysate-based Cell-free Systems
    14:42

    Liquid Chromatography Coupled to Refractive Index or Mass Spectrometric Detection for Metabolite Profiling in Lysate-based Cell-free Systems

    Published on: September 23, 2021

    5.8K
    An HS-MRM Assay for the Quantification of Host-cell Proteins in Protein Biopharmaceuticals by Liquid Chromatography Ion Mobility QTOF Mass Spectrometry
    11:09

    An HS-MRM Assay for the Quantification of Host-cell Proteins in Protein Biopharmaceuticals by Liquid Chromatography Ion Mobility QTOF Mass Spectrometry

    Published on: April 17, 2018

    10.7K

    Related Experiment Videos

    Last Updated: Mar 26, 2026

    Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application
    04:24

    Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application

    Published on: June 16, 2023

    2.5K
    Liquid Chromatography Coupled to Refractive Index or Mass Spectrometric Detection for Metabolite Profiling in Lysate-based Cell-free Systems
    14:42

    Liquid Chromatography Coupled to Refractive Index or Mass Spectrometric Detection for Metabolite Profiling in Lysate-based Cell-free Systems

    Published on: September 23, 2021

    5.8K
    An HS-MRM Assay for the Quantification of Host-cell Proteins in Protein Biopharmaceuticals by Liquid Chromatography Ion Mobility QTOF Mass Spectrometry
    11:09

    An HS-MRM Assay for the Quantification of Host-cell Proteins in Protein Biopharmaceuticals by Liquid Chromatography Ion Mobility QTOF Mass Spectrometry

    Published on: April 17, 2018

    10.7K

    Area of Science:

    • Biochemistry
    • Mass Spectrometry
    • Clinical Diagnostics

    Background:

    • Serum free light chains (FLC) are by-products of immunoglobulin production by plasma cells.
    • Healthy individuals exhibit polyclonal FLC, while plasma cell dyscrasias involve monoclonal FLC secretion.
    • Monoclonal FLC in conditions like multiple myeloma and light chain amyloidosis are diagnostic markers.

    Purpose of the Study:

    • To adapt the monoclonal immunoglobulin rapid accurate mass measurement (miRAMM) methodology for FLC detection.
    • To evaluate the application of miRAMM for quantifying non-reduced free light chains in serum.
    • To assess the diagnostic utility of miRAMM for identifying monoclonal FLC in plasma cell dyscrasias.

    Main Methods:

    • Utilized microLC-ESI-Q-TOF mass spectrometry on non-reduced serum samples.
    • Applied monoclonal immunoglobulin rapid accurate mass measurement (miRAMM) for FLC analysis.
    • Validated linearity and precision using purified FLC spiked into normal serum.

    Main Results:

    • Monoclonal free light chains (FLC) were detected and quantified in a cohort of 27 light chain amyloidosis patients.
    • The miRAMM method identified monoclonal FLC in 23 out of 27 patients with abnormal FLC levels by immunonephelometry.
    • Proof-of-concept experiments demonstrated linearity and precision for FLC quantification.

    Conclusions:

    • Mass spectrometry-based miRAMM accurately detects and quantifies monoclonal FLC without needing κ/λ ratios.
    • The method's high resolution and mass accuracy allow simultaneous monitoring of polyclonal FLC background and monoclonal FLC.
    • This approach offers a precise tool for diagnosing and monitoring plasma cell dyscrasias.